GlassScriptPhysician profile
Peter S Vezeridis
NPI 1902001589
$27,979.08
in general payments reported to CMS, 2019-2025
17 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,501 · 2020: $8,195 · 2021: $7,554 · 2022: $1,946 · 2023: $5,417 · 2024: $261 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,681 · Food and Beverage: $958 · Travel and Lodging: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,680.92 |
| Food and Beverage | $958.04 |
| Travel and Lodging | $143.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $16,619.56 | 2019-2023 | Healix Knotless Peek |
| Medical Device Business Services, INC. | $8,940.87 | 2019-2023 | Healix Knotless Peek, Na, N/A |
| Pacira Therapeutics, INC. | $663.30 | 2019-2021 | |
| Stryker Corporation | $413.05 | 2019-2024 | Blueprint Patient Specific Instrumentation |
| Vericel Corporation | $297.61 | 2019-2025 | Maci |
| Depuy Synthes Sales INC. | $227.73 | 2022-2023 | Healix Knotless Peek |
| Linvatec Corporation | $192.03 | 2019 | |
| Fidia Pharma USA INC. | $147.63 | 2019-2025 | Hymovis, Triluron, Hyalgan |
| Zimmer Biomet Holdings, INC. | $122.62 | 2019 | |
| Kairos Surgical INC | $108.63 | 2021 | |
| Encore Medical, LP | $71.97 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $58.15 | 2022-2023 | Exparel, Zilretta, Iovera |
| Fx Shoulder Solutions, INC | $45.07 | 2019 | |
| Baudax Bio INC. | $22.06 | 2022 | |
| Smith+Nephew, INC. | $18.72 | 2025 | N/A |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impactortho, INC. | $15.61 | 2023 | |
| Ferring Pharmaceuticals INC. | $14.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Vezeridis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.